Skip to main content

Table 2 Intravaginal practices in the month prior to enrollment and laboratory parameters at baseline (vaginal flora, BV, HIV plasma and genital viral load, IL-6 and IL-8) by condition. (n = 128)

From: A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study

  

Condition

N(%)

Median(IQR)

 
 

All

Experimental (n = 58)

SOC+ (n = 70)

p-value

Product use for IVP in the prior month

 Water

    

  No

10 (7.8%)

5 (8.6%)

5 (7.1%)

 

  Yes

118 (92.2%)

53 (91.4%)

65 (92.9%)

0.755a

 Soap

  No

39 (30.5%)

22 (37.9%)

17 (24.3%)

 

  Yes

89 (69.5%)

36 (62.1%)

53 (75.7%)

0.095

 Cloth, sponge or a rag

  No

33 (47.1%)

27 (46.6%)

33 (47.1%)

 

  Yes

68 (53.1%)

31 (53.4%)

37 (52.9%)

> 0.999

 Traditional medicines

    

  No

91 (71.1%)

43 (74.1%)

48 (68.6%)

 

  Yes

37 (28.9%)

15 (25.9%)

22 (31.4%)

0.489

 Herbs or flowers from outdoors

  No

103 (80.5%)

46 (79.3%)

57 (81.4%)

 

  Yes

25 (19.5%)

12 (20.7%)

13 (18.6%)

0.763

 Lemon

  No

115 (89.3%)

52 (89.7%)

63 (90.0%)

 

  Yes

13 (10.2%)

6 (10.3%)

7 (10.0%)

> 0.999

 Salt

  No

117 (91.4%)

54 (93.1%)

63 (90.0%)

 

  Yes

11 (8.6%)

4 (6.9%)

7 (10.0%)

0.753a

 Vinegar

  No

124 (96.9%)

56 (96.6%)

68 (97.1%)

 

  Yes

4 (3.1%)

2 (3.4%)

2 (2.9%)

0.848a

Laboratory parameters

 Abnormal vaginal flora

  No

30 (23.4%)

16 (27.6%)

14 (20.0%)

 

  Yes

98 (76.6%)

42 (72.4%)

56 (80.0%)

0.213

 Bacterial vaginosis

  No

47 (36.7%)

24 (41.4%)

23 (32.9%)

 

  Yes

81 (63.3%)

34 (58.6%)

47 (67.1%)

0.319

 Plasma HIV RNA

  Undetectable

100 (78.1%)

46 (79.3%)

54 (77.1%)

 

  Detectable

28 (21.9%)

12 (20.7%)

16 (22.9%)

0.768

 CVL HIV RNA

  Undetectable

108 (84.4%)

50 (86.2%)

58 (82.9%)

 

  Detectable

20 (15.6%)

8 (13.8%)

12 (17.1%)

0.603

 Lower genital tract cytokines

  IL-6 (n = 68; Exp = 35, SOC+ = 33)

289.9 (258.0)

306.3 (313.7)

282.6 (249.1)

0.944

  IL-8 (n = 68; Exp = 35, SOC+ = 33)

332.5 (1781.9)

380.11 (1311.9)

227.5 (2285.5)

< 0.001

  1. CD4 cells/ml was self-reported
  2. Plasma and CVL HIV RNA limit of detection was 20 copies/milliliter
  3. CVL cervicovaginal lavage
  4. IVP intravaginal practices
  5. SOC+ enhanced standard of care
  6. Note. aFisher’s Exact test was used